CorMedix (CRMD) Tops Q1 EPS by 1c

CorMedix (NASDAQ: CRMD) reported Q1 EPS of ($0.24), $0.01 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on CorMedix (CRMD) click here.

You May Also Be Interested In

• Wells Fargo cuts Netflix rating on engagement risk, weak slate
• Premarket movers: Xenon sinks on trial pause, Netflix hit by downgrade
• Restaurant Brands International (QSR) PT Raised to $86 at Guggenheim